Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury

scientific article published on 01 June 2002

Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPGI.00073.2001
P698PubMed publication ID12016132

P50authorRosemary A. KozarQ112372091
P2093author name stringFrederick A Moore
Lei Zou
Bruce C Kone
Heitham T Hassoun
Norman W Weisbrodt
P433issue6
P921main subjectreperfusion injuryQ1413991
P304page(s)G1059-68
P577publication date2002-06-01
P1433published inAmerican Journal of Physiology - Gastrointestinal and Liver PhysiologyQ15765756
P1476titleAlpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury
P478volume282

Reverse relations

cites work (P2860)
Q36681505AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality
Q36728787Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms
Q46938298Alpha-MSH rescues neurons from excitotoxic cell death
Q36254148Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers
Q79167572Delayed Administration of ??-Melanocyte-Stimulating Hormone or Combined Therapy with Bay 11-7085 Protects Against Gut Ischemia???Reperfusion Injury
Q36466000Development of intestinal ischemia/reperfusion-induced acute kidney injury in rats with or without chronic kidney disease: Cytokine/chemokine response and effect of α-melanocyte-stimulating hormone
Q42596989Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut.
Q41873262Effects of α-MSH on ischemia/reperfusion injury in the rat sciatic nerve
Q46375880Induction of cell death in rat small intestine by ischemia reperfusion: differential roles of Fas/Fas ligand and Bcl-2/Bax systems depending upon cell types
Q37175638Intestinal edema: effect of enteral feeding on motility and gene expression
Q54463873Intestinal ischemic preconditioning after ischemia/reperfusion injury in rat intestine: profiling global gene expression patterns.
Q35916693Ischemia-reperfusion injury of the intestine and protective strategies against injury
Q34988063MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer
Q78339319Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy
Q38005251Melanocortins as potential therapeutic agents in severe hypoxic conditions
Q40663646Murine Model of Intestinal Ischemia-reperfusion Injury
Q37238435Pretreatment with bone morphogenetic protein-7 (BMP-7) mimics ischemia preconditioning following intestinal ischemia/reperfusion injury in the intestine and liver
Q61448838Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases
Q34358639Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice
Q42451659Protein kinase C-ϵ modulates mitochondrial function and active Na+transport after oxidant injury in renal cells
Q36081681Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut.
Q42757138The effects of apelin on mesenteric ischemia and reperfusion damage in an experimental rat model
Q35594078Transforming growth factor-beta 3 alters intestinal smooth muscle function: implications for gastroschisis-related intestinal dysfunction

Search more.